Advances in Hidradenitis Suppurativa

Multimedia Medical Education

Supported by an educational grant from AbbVie.*
Medical accuracy confirmed at release date.

Recent Advances in Our Understanding and Management of HS: From Mild to Worsening HS
from Choose Your Own HS Adventure: Going Beyond Current Guidelines
EADV 2019
Thrasyvoulos Tzellos, MD, MSc, PhD
Afsaneh Alavi, MD
Falk G. Bechara, MD
Release Date: 12 November 2019
What Would You Do? Combined Medical and Surgical Approaches in Moderate-to-Severe HS
from Choose Your Own HS Adventure: Going Beyond Current Guidelines
EADV 2019
Thrasyvoulos Tzellos, MD, MSc, PhD
Afsaneh Alavi, MD
Falk G. Bechara, MD
Release Date: 12 November 2019
What Would You Do? Troubling Cases of HS
from Choose Your Own HS Adventure: Going Beyond Current Guidelines
EADV 2019
Thrasyvoulos Tzellos, MD, MSc, PhD
Afsaneh Alavi, MD
Falk G. Bechara, MD
Release Date: 12 November 2019
Ask the Faculty
from Choose Your Own HS Adventure: Going Beyond Current Guidelines
EADV 2019
Thrasyvoulos Tzellos, MD, MSc, PhD
Afsaneh Alavi, MD
Falk G. Bechara, MD
Release Date: 12 November 2019
Modifying the Impact of HS: Lifestyle Considerations
from Ticking All the Boxes: A Multidisciplinary Approach to Hidradenitis Suppurativa
EADV 2018
Thrasyvoulos Tzellos, MD, MSc, PhD
Release Date: 15 October 2018
Addressing the Psychosocial Symptoms of HS
from Ticking All the Boxes: A Multidisciplinary Approach to Hidradenitis Suppurativa
EADV 2018
Errol P. Prens, MD, PhD
Release Date: 15 October 2018
Easing the Pain: Approaches for Clinicians Managing HS
from Ticking All the Boxes: A Multidisciplinary Approach to Hidradenitis Suppurativa
EADV 2018
Falk G. Bechara, MD
Release Date: 15 October 2018
What’s the Goal? Perspectives on What We Want to Achieve for Patients With HS
from Ticking All the Boxes: A Multidisciplinary Approach to Hidradenitis Suppurativa
EADV 2018
Errol P. Prens, MD, PhD
Release Date: 15 October 2018

Faculty Communications

Case Studies, Literature Reviews, and Survey Results

Highlights from the 6th EHSF Conference in 2017
Kelsey R. van Straalen, MD
Hessel H van der Zee, MD

Join the Discussion
Survey Report: How Do Clinicians Approach the Management of Hidradenitis Suppurativa?
Caitriona Ryan, MD

Join the Discussion
Literature Review: Evaluating the Psychological Burden of HS and Its Impact on Relationships and Sexual Function
Hessel H van der Zee, MD, PhD

Join the Discussion

Patient Case Studies

65-year-old woman, who was hospitalized for multiple erythematous plaques and placards, with fine squames and telangiectasis...

72-year-old male psoriasis patient who developed generalized pustular psoriasis flare after administration of CoronoVac....

30-year-old female who was pregnant with a gestational age of 27 weeks and diagnosed with severe preeclampsia, SLE and psoriasis...

See more >>

In the News

Increased Mortality After MI in Young Adults With Systemic Inflammatory Disease
Myocardial infarctions (MI) in young adults are twice as likely to be fatal in those with inflammatory conditions like psoriasis, lupus, or rheumatoid arthritis, according to results from a study published in the European Journal of Preventive Cardiology. “This suggests that the worse long-term...
AAD Releases First-Ever Guidelines for Treating Paediatric Patients With Psoriasis
The American Academy of Dermatology (AAD) and the National Psoriasis Foundation (NPF) have released guidelines to help ensure that paediatric psoriasis patients receive the best possible treatment and care. The joint AAD/NPF guidelines, published in the Journal of the American Academy of...
Psoriasis Appears Associated With Increased Risk of Developing, Dying of Cancer
Patients with psoriasis appear to have an increased risk of cancer incidence and cancer-related mortality, according to a study published in JAMA Dermatology. For the study, Alex Trafford, University of Manchester, Manchester, United Kingdom, and colleagues searched through 6 electronic databases...
See more >>

Conference Reports

Weak Antibody Response, But Not T Cell Response After First Dose of mRNA COVID-19 Vaccine in Patients With Psoriasis on Methotrexate

By Shazia Qureshi

VIRTUAL -- July 14, 2021 -- In patients with psoriasis being treated with methotrexate, 1 dose of Pfizer’s BioNTech mRNA coronavirus disease 2019 (COVID‑19) BNT162b2 vaccine (BNT162b2) led to a lower immune response -- both in neutralising antibodies and immunoglobulin G...

Efficacy of Upadacitinib for Psoriatic Arthritis Maintained for Up to 56 Weeks

By Erika Powers

VIRTUAL -- June 10, 2021 -- Patients with psoriatic arthritis who were treated with upadacitinib 15 mg or 30 mg maintained responses for over 56 weeks, with rates numerically higher than treatment with adalimumab, according to a study presented at the Virtual 2021 Annual...

Deucravacitinib Effective for Patients With Active Psoriatic Arthritis

By Louise Gagnon

OTTAWA, Ontario -- November 12, 2020 -- Deucravacitinib was effective, compared with placebo, over 16 weeks of treatment in patients with active psoriatic arthritis (PsA), according to a study presented at the 2020 Virtual Meeting of the American College of Rheumatology (...

see more >>

Recently Published

IL-36α and IL-36γ expressions in the differential diagnosis of palmoplantar psoriasis and palmoplantar eczema: A retrospective histopathologic and immunohistochemical study
Ozan Erdem, Cem Leblebici, Ayşe Esra Koku Aksu, Duygu Erdil, Asude Kara Polat, Mehmet Salih Gürel
Subclinical Liver Disease is Associated with Subclinical Atherosclerosis in Psoriasis: Results from Two Observational Studies
Alvaro Gonzalez-Cantero, Meron Teklu, Alexander V Sorokin, Ronald Prussick, Jorge González-Cantero, Jose Luis Martin-Rodriguez, Nidhi Patel, Philip M Parel, Grigory A Manyak, Heather L Teague, Justin A Rodante, Andrew Keel, Cristina Pérez-Hortet, Ana I Sanchéz-Moya, Natalia Jiménez, Asunción Ballester, Jorge Solis, Leticia Fernandez-Friera, María G Barderas, Jorge L Gonzalez-Calvin, Pedro Jaen, Martin P Playford, Amit K Dey, Joel M Gelfand, Nehal N Mehta
Treating the skin with biologics in patients with psoriasis decreases the incidence of psoriatic arthritis
Maria Laura Acosta Felquer, Luciano LoGiudice, Maria Laura Galimberti, Javier Rosa, Luis Mazzuoccolo, Enrique R Soriano
See more >>

Full-Text Articles

Scientific Reports
Low hemoglobin levels and an increased risk of psoriasis in patients with chronic kidney disease
Si-Hyung Lee, Miri Kim, Kyung-Do Han, Ji Hyun Lee
Scientific Reports
Growth arrest and DNA damage-inducible proteins (GADD45) in psoriasis
Pedro Rodríguez-Jiménez, Lola Fernández-Messina, María C Ovejero-Benito, Pablo Chicharro, Paula Vera-Tomé, Alicia Vara, Danay Cibrian, Pedro Martínez-Fleta, María Jiménez-Fernández, Inés Sánchez-García, Mar Llamas-Velasco, Francisco Abad-Santos, Francisco Sánchez-Madrid, Esteban Dauden, Hortensia de la Fuente
Reumatología Clinica
Psoriatic arthritis: interaction between cardiometabolic diseases and inflammatory burden of the disease
José Andrés Lorenzo Martín, Estefanía Pardo Campo, Marina Pino Martinez, María Colazo Burlato, Manuel Rubén Queiro Silva
See more >>

Hessel H van der Zee, MD, PhD and Caitriona Ryan, MD, invite you to explore the education and resources on this site, designed to provide a comprehensive approach to managing patients with hidradenitis suppurativa.

Hessel H van der Zee, MD, PhD
Erasmus University Medical Center
Rotterdam, the Netherlands

Caitriona Ryan, MD
St. Vincent's Hospital
Dublin, Ireland


User-friendly learning modules available in short and accessible formats.

Insights and developments in HS from leading experts.

Continuously updated news and conference coverage.

Helpful resources for your practice and patients.